Research Solutions Inc Stock Price, News & Analysis

Research Solutions (NASDAQ: RSSS) will hold a conference call on February 9, 2023, at 5:00 p.m. ET to discuss its financial results for the second fiscal quarter ending December 31, 2022.

The call will be hosted by President and CEO Roy W. Olivier and CFO Bill Nurthen. Details for participating include a dial-in number of 1-631-891-4304 and Conference ID 10020971. A replay will be available post-call until March 9, 2023.

Research Solutions, founded in 2006, provides cloud-based technologies and serves over 70% of top pharmaceutical companies and prestigious universities.

Research Solutions, Inc. (NASDAQ: RSSS) will be participating in the Healthcare IT Virtual Conference on January 25th, 2023, at 12:00 PM ET. CEO Roy W. Olivier and CFO Bill Nurthen will represent the company during the event presented by Maxim Group LLC. Interested listeners can sign up via the M-Vest website or through a provided link.

Founded in 2006, Research Solutions specializes in cloud-based technologies for research and development organizations, serving over 70% of top pharmaceutical companies and universities with its Article Galaxy platform.

Research Solutions, Inc. (NASDAQ: RSSS) reported total revenue of $8.7 million for Q1 2023, representing a 12% increase year-over-year. The company saw platform revenue surge 34% to $2.0 million and Annual Recurring Revenue (ARR) rise 33% to $8.3 million. Net income reached $215,000 or $0.01 per diluted share, reversing a loss of ($372,000) from the prior year. The gross profit increased 26%, with a gross margin improvement to 38.6%. The company recorded positive cash flow from operations of $109,000.

Research Solutions, Inc. (NASDAQ: RSSS) is set to announce its financial results for the first fiscal quarter ending September 30, 2022, on November 10, 2022, at 5:00 p.m. ET. The conference call will feature CEO Roy W. Olivier and CFO Bill Nurthen, who will discuss the results followed by a Q&A session. Investors can access the call via a dial-in number or through the company's investor relations website. A replay will be available until December 10, 2022.

Research Solutions (NASDAQ: RSSS) has launched Curedatis, a SaaS platform aimed at streamlining literature review workflows for medical device companies. This innovative tool enhances the clinical evaluation process by enabling rapid article screening and maintaining regulatory compliance through intelligent documentation. Key features include simplified searching, ultra-fast screening utilizing PICO terms, and centralized article access via the Article Galaxy platform, which reduces time spent on data duplication. Curedatis addresses critical challenges in clinical evaluations for healthcare professionals.

Research Solutions, Inc. (NASDAQ: RSSS) has announced the acquisition of selected customer contracts from FIZ Karlsruhe's AutoDoc service, which serves approximately 700 global customers. This strategic move is expected to enhance transaction revenues and provide opportunities to cross-sell to the Article Galaxy Platform. The contract assumption will take effect on January 1, 2023, with revenue recognition starting in the fiscal third quarter. The acquisition aims to expand Research Solutions' customer base and geographic reach, aligning with their strategy for greater recurring revenue and business growth.

Research Solutions, Inc. (NASDAQ: RSSS) reported a 4% increase in total revenue to $8.6 million for Q4 FY2022, driven by a 32% rise in platform revenue, reaching $1.9 million. The company achieved a 35% increase in annual recurring revenue (ARR), totaling $7.9 million, and added 53 net new platform deployments. Despite these gains, Research Solutions recorded a net loss of $438,000, translating to $0.02 per share, and a negative adjusted EBITDA of $121,000. For the fiscal year, total revenue grew to $32.9 million, but net loss widened to $1.6 million.

Research Solutions, Inc. (NASDAQ: RSSS) is scheduled to announce its fourth quarter and full fiscal year results for the period ending June 30, 2022, on September 22, 2022. The conference call will be hosted by President and CEO Roy W. Olivier and CFO Bill Nurthen at 5:00 p.m. ET. Interested parties can join the call or access it via the investor relations section of the company's website afterward. Research Solutions provides cloud-based technologies focused on research and development, serving over 70% of top pharmaceutical companies and universities.

Research Solutions, Inc. (NASDAQ: RSSS) will participate in the Midwest IDEAS Investor Conference on August 25, 2022. President & CEO Roy W. Olivier and CFO Bill Nurthen are scheduled to host investor meetings, with their presentation set for 11:15 am ET. The event will be accessible via webcast at Three Part Advisors. Founded in 2006, Research Solutions offers cloud-based technologies for managing intellectual property, serving over 70% of leading pharmaceutical companies and universities.